ArticleTuberculosis and respiratory diseases2017

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?

Yeon-Mok OhPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.